Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Memorial Sloan-Kettering Cancer Center
 More »

  • microRNA.org
    MicroRNA.org is the brainchild of the Computational Biology Center at the Memorial Sloan-Kettering Cancer Center. It contains predicted target information for a large number of ...
    8-1-2013
  • Six Websites You Need to Bookmark: August Picks
    ... MicroRNA.org is the brainchild of the Computational Biology Center at the Memorial Sloan-Kettering Cancer Center. It contains predicted target information for a large number of ...
    7-22-2013
  • Targeting Deranged Metabolism to Treat Cancer
    ... In one study, led by Dan Rohie of the human oncology and pathogenesis program at Memorial Sloan Kettering Cancer Center, the investigators determined the role of mutant IDH1 in ...
    7-1-2013
  • Cancer's Bitter Medicine
    ... In advocating lower prices, the CML group hopes to repeat the success of Memorial Sloan-Kettering Cancer Center, where physicians refused to prescribe Zaltrap (ziv-aflibercept) for ...
    6-15-2013
  • Targeting Deranged Metabolism to Treat Cancer
    ... In one study, led by Dan Rohie of the human oncology and pathogenesis program at Memorial Sloan Kettering Cancer Center, the investigators determined the role of mutant IDH1 in ...
    5-30-2013
  • Cancer's Bitter Medicine
    ... In advocating lower prices, the CML group hopes to repeat the success of Memorial Sloan-Kettering Cancer Center, where physicians refused to prescribe Zaltrap (ziv-aflibercept) for ...
    5-21-2013
  • Moving Genomics Closer to the Clinic
    Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment. Foundation Medicine and Memorial ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... CDx Under Development Foundation Medicine and Memorial Sloan-Kettering Cancer Center Agreement announced May 2 Collaboration to co-develop a new molecular diagnostic intended to ...
    5-9-2013
  • Foundation Medicine Taps Sloan-Kettering Clinical, Genomics Expertise...
    Foundation Medicine and New York's Memorial Sloan-Kettering Cancer Center are partnering to co-develop a new molecular diagnostic intended to match patients with blood cancers to ...
    5-2-2013
  • Women and Smoking
    ... Genetic Mutations In 2012, investigators led by pathologist Mark Ladanyi, M.D., at Memorial Sloan Kettering Cancer Center studied genotyped 3,026 lung adenocarcinomas for the major ...
    4-3-2013
  • Cell Therapy Leads to ALL Remission
    the field of targeted immunotherapy," Michel Sadelain, M.D., Ph.D., director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, said in a statement. Dr. ...
    3-21-2013
  • A Windfall for Rock Star Researchers
    ... of the human genome Charles L. Sawyers , chair, human oncology and pathogenesis program at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute Investigator. ...
    2-21-2013
  • Pancreatic Cancer Research Gets $25M Boost
    The David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Memorial Sloan-Kettering Cancer Center, and Cold Spring Harbor Laboratory. ...
    1-23-2013
  • NCI Grants MabVax $150K for Neuroblastoma Vaccine
    The vaccine was developed at Memorial Sloan-Kettering Cancer Center, where preclinical and early clinical development work was completed. Stemming from a deal inked in 2008 , ...
    12-18-2012
  • NY Genome Center Names President-Scientific Director
    The center also has from Life Technologies four Ion Proton sequencers, housed at Memorial Sloan-Kettering Cancer Center. Over time, the consortium plans to grow to 500 ...
    11-27-2012

  • Journal Articles

  • The Results of Selective Use of Radioactive Iodine on Survival...
    Iain J. Nixon, Ian Ganly, Snehal G. Patel, Frank L. Palmer, Monica M. Di Lorenzo, Ravinder K. Grewal, Steven M. Larson, R. Michael Tuttle, Ashok Shaha, Jatin P. Shah
    Thyroid
    The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan-Kettering Cancer Center Risk ...
  • Humidified High-Flow Nasal Oxygen Utilization in Patients with...
    Andrew S. Epstein, Sidonie K. Hartridge-Lambert, Judson S. Ramaker, Louis P. Voigt, Carol S. Portlock
    Journal of Palliative Medicine
    Humidified High-Flow Nasal Oxygen Utilization in Patients with Cancer at Memorial Sloan-Kettering Cancer Center Journal of Palliative Medicine Abstract Background: Respiratory ...
  • Comparison with Published Systems of a New Staging System for...
    RONNIE WONG, Catherine Bresee, Glenn Braunstein
    Thyroid
    Cancer Center (UAB-MDACC); the Tumor, Nodal and Metastasis (TNM) 5th and 7th editions; Memorial Sloan Kettering (MSK); the National Thyroid Cancer Treatment Cooperative Study ...
  • A Pilot Study of Website Information Regarding Aromatase Inhibitors...
    Cara L. McDermott, Angela A. Hsieh, Erin S. Sweet, Kimberly M. Tippens, Jeannine S. McCune
    Journal of Alternative and Complementary Medicine, The
    most reliable, unbiased, and comprehensive information on AI-DS interactions at the Natural Medicines Comprehensive Database and Memorial Sloan-Kettering Cancer Center websites. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll